OncoZenge AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '25 Apr 24, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	50	44	36	64	135	-
Market Cap Growth	21.36%	21.36%	-43.82%	-52.42%	-	-
Enterprise Value	47	38	20	32	80	-
Last Close Price	4.30	3.75	3.09	5.50	11.56	-
PS Ratio	50366.95	43924.67	12064.64	-	-	-
PB Ratio	5.06	4.42	1.94	1.90	1.69	-
P/TBV Ratio	16.25	14.17	3.07	2.38	1.84	-
EV/Sales Ratio	-	38094.67	6750.97	-	-	-
EV/EBITDA Ratio	-	-	2.79	11.43	-	-
Quick Ratio	2.95	2.95	7.81	10.22	10.62	1.72
Current Ratio	3.09	3.09	7.94	10.29	10.63	1.72
Return on Equity (ROE)	-60.77%	-60.77%	-60.45%	-81.62%	-7.09%	-
Return on Assets (ROA)	-34.17%	-34.17%	-34.73%	-20.88%	-4.95%	-
Return on Capital (ROIC)	-37.97%	-37.97%	-37.78%	-22.31%	-5.58%	-
Earnings Yield	-17.25%	-19.78%	-43.94%	-72.41%	-2.87%	-
Buyback Yield / Dilution	-	-	-	0.53%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.